Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.16 USD | +0.42% | +7.67% | +6.87% |
20/05 | Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating | MT |
17/05 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.87% | 267.52Cr | |
+30.52% | 47TCr | |
+33.63% | 28TCr | |
+3.90% | 14TCr | |
+30.50% | 9.48TCr | |
+62.27% | 6.11TCr | |
+14.09% | 4.66TCr | |
+25.91% | 3.81TCr | |
-0.62% | 3.57TCr | |
+12.07% | 2.91TCr |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- Goldman Sachs Raises Price Target on GoodRx to $6.50 From $6, Maintains Neutral Rating